NCT06430723Completed
The Impact of Obesity on Short Stem Total Hip Arthroplasty
Obesity and it's Impact on Subsidence and Clinical Outcomes After Short Stem Total Hip
Source: ClinicalTrials.gov · Last updated 11 Jun 2024
Brief summary (registry, in English)
The purpose of this study is to review the impact of obesity on subsidence and clinical outcome after short stem total hip arthroplasty.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 21 May 2024
- Start date
- 1 Jan 2018
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Krankenhaus Barmherzige Schwestern Linz
- Diseases
- Obesity
- NCT number
- NCT06430723
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 1 Jan 2018 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- former surgeries of the hip in question
- incomplete clinical data
- incomplete radiological data
Who the study is looking for
- patients who underwent primary short stem hip arthroplasty with Mathys Optimys short stem between 01.01.2018 and 31.12.2020
- availability of preoperative and postoperative radiographs for assessment of subsidence
- a minimum BMI of 30kg/m2 for the obese group
- a minimum follow-up of 24 months.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ordensklinikum Linz, Barmherzige Schwestern Abteilung Orthopädie Coordinator of this site? Confirm its status | Linz | Austria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.